lactic acid has been researched along with Cicatrization in 37 studies
Lactic Acid: A normal intermediate in the fermentation (oxidation, metabolism) of sugar. The concentrated form is used internally to prevent gastrointestinal fermentation. (From Stedman, 26th ed)
2-hydroxypropanoic acid : A 2-hydroxy monocarboxylic acid that is propanoic acid in which one of the alpha-hydrogens is replaced by a hydroxy group.
Cicatrization: The formation of fibrous tissue in the place of normal tissue during the process of WOUND HEALING. It includes scar tissue formation occurring in healing internal organs as well as in the skin after surface injuries.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To investigate the efficacy and histologic differences of intradermal injection of a filler (poly-d, l-lactic acid, PDLA) using an MFRF device for the treatment of acne scars." | 9.51 | Intradermal Injection of Poly-d, l-Lactic Acid Using Microneedle Fractional Radiofrequency for Acne Scars: An Open-Label Prospective Trial. ( Hyeong, JH; Jung, JW; Kim, HS; Kim, KH; Seo, SB, 2022) |
| "To determine the degree of correction attainable with poly-L-lactic acid and safety findings for the treatment of hill and valley acne scarring." | 9.20 | A Canadian study of the use of poly-L-lactic acid dermal implant for the treatment of hill and valley acne scarring. ( Mraud, K; Sapra, S; Schupp, R; Stewart, JA, 2015) |
| "This report describes a novel use of injectable poly-L-lactic acid (PLLA; Sculptra) for the correction of acne scars in an adult patient." | 7.75 | Case study involving use of injectable poly-L-lactic acid (PLLA) for acne scars. ( Palmisano, L; Sadick, NS, 2009) |
| "To investigate the efficacy and histologic differences of intradermal injection of a filler (poly-d, l-lactic acid, PDLA) using an MFRF device for the treatment of acne scars." | 5.51 | Intradermal Injection of Poly-d, l-Lactic Acid Using Microneedle Fractional Radiofrequency for Acne Scars: An Open-Label Prospective Trial. ( Hyeong, JH; Jung, JW; Kim, HS; Kim, KH; Seo, SB, 2022) |
| "Acne vulgaris affects up to 80% of people 11 to 30 years of age, and scarring can occur for up to 95% of these patients." | 5.35 | Injectable poly-L: -lactic acid: a novel sculpting agent for the treatment of dermal fat atrophy after severe acne. ( Sadove, R, 2009) |
| "Acne scars may negatively impact quality of life." | 5.34 | A single-center, open-label study on the use of injectable poly-L-lactic acid for the treatment of moderate to severe scarring from acne or varicella. ( Beer, K, 2007) |
| "To determine the degree of correction attainable with poly-L-lactic acid and safety findings for the treatment of hill and valley acne scarring." | 5.20 | A Canadian study of the use of poly-L-lactic acid dermal implant for the treatment of hill and valley acne scarring. ( Mraud, K; Sapra, S; Schupp, R; Stewart, JA, 2015) |
| "The Jessner's-trichloroacetic acid (TCA) peel is a procedure developed by Monheit to produce a safe, effective medium-depth chemical peel for the treatment of photoaged skin, actinic keratoses, and superficial acne scars." | 4.79 | The Jessner's-trichloroacetic acid peel. An enhanced medium-depth chemical peel. ( Monheit, GD, 1995) |
| "This report describes a novel use of injectable poly-L-lactic acid (PLLA; Sculptra) for the correction of acne scars in an adult patient." | 3.75 | Case study involving use of injectable poly-L-lactic acid (PLLA) for acne scars. ( Palmisano, L; Sadick, NS, 2009) |
| "Polylactic acid glue can effectively reduce epidural cicatrization and adhesion." | 3.73 | Effect of polylactic acid glue in preventing epidural scar adhesion after laminectomy in rabbits. ( Ding, YL; Duan, H; Liu, LM; Lu, B; Song, YM, 2006) |
| "The incidence of inflammation, suppuration and hypertrophic scarring was recorded, along with the timing of spontaneous suture disappearance." | 2.69 | Outcomes of irradiated polyglactin 910 Vicryl Rapide fast-absorbing suture in oral and scalp wounds. ( Aderriotis, D; Sàndor, GK, 1999) |
| "Corticosteroids may be beneficial in treating vocal fold scarring." | 1.42 | Dexamethasone Controlled Release on TGF-β1 Treated Vocal Fold Fibroblasts. ( Kosinski, AM; Panitch, A; Pothen, JM; Sivasankar, MP, 2015) |
| "Atrophic scars represent a loss of collagen and a challenging reconstructive dilemma with disappointing traditional treatments." | 1.40 | Treatment of atrophic scars with fractionated CO2 laser facilitating delivery of topically applied poly-L-lactic acid. ( Ozog, D; Rkein, A; Waibel, JS, 2014) |
| " We found that MMWC was toxic for two parasite forms." | 1.39 | In vitro analysis regarding the safety of components used in a film-based therapeutic system loaded with meglumine antimoniate and its activity toward Leishmania major experimental infections: a preliminary study. ( Barbosa, H; Delgado, G; Gutiérrez, J; Pinzón, J; Vallejo, B, 2013) |
| "Although antiscarring agents help prevent postsurgical scarring and improve glaucoma surgical outcomes, they may be associated with an increased incidence of severe and potentially blinding complications." | 1.39 | Effect of poly(DL-lactide-co-glycolide) on scar formation after glaucoma filtration surgery. ( DU, LQ; Li, Y; Wang, SG; Wu, XY; Yang, HL, 2013) |
| "Acne vulgaris affects up to 80% of people 11 to 30 years of age, and scarring can occur for up to 95% of these patients." | 1.35 | Injectable poly-L: -lactic acid: a novel sculpting agent for the treatment of dermal fat atrophy after severe acne. ( Sadove, R, 2009) |
| "For the glabellar region, severe partly vascular adverse events have been reported after treatment with injectable fillers." | 1.35 | The spectrum of adverse reactions after treatment with injectable fillers in the glabellar region: results from the Injectable Filler Safety Study. ( Bachmann, F; Erdmann, R; Hartmann, V; Rzany, B; Wiest, L, 2009) |
| "Acne scars may negatively impact quality of life." | 1.34 | A single-center, open-label study on the use of injectable poly-L-lactic acid for the treatment of moderate to severe scarring from acne or varicella. ( Beer, K, 2007) |
| "However, fragile scar adhered with dura mater diffusely and more FB were observed in CG." | 1.33 | [Experimental study on the polylactic acid glue in preventing epidural adhesion]. ( Ding, Y; Duan, H; Liu, L; Lu, B; Song, Y, 2005) |
| "We observed a dense, fibrous scar and encapsulation at the implantation site." | 1.32 | Complications of bioabsorbable orbital implants and fixation plates. ( Burgett, R; Huynh, TH; Ng, JD, 2004) |
| "Epidural scar formation and adhesion were observed grossly and histologically." | 1.32 | [Experimental study on the prevention of epidural scar adhesion with polycaprolactone/polylactic acid membrane]. ( Ji, HR; Pang, XD; Xiao, G; Xu, XX; Yan, JJ; Yang, CD; Yu, DH; Zhang, ZW; Zhu, D, 2004) |
| "Multiple modalities are available for treating acne scars, one of which is chemical peeling." | 1.31 | Medium-depth chemical peels in the treatment of acne scars in dark-skinned individuals. ( Al-Sharqi, AI; Al-Waiz, MM, 2002) |
| "The results of treating hypertrophic scars with urea preparations are also to be evaluated optimistically." | 1.26 | [Formation and treatment of pathologic scars--clinical and micromorphologic investigations (author's transl)]. ( Auböck, L; Bayer, U; Kerl, H, 1981) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (8.11) | 18.7374 |
| 1990's | 8 (21.62) | 18.2507 |
| 2000's | 15 (40.54) | 29.6817 |
| 2010's | 10 (27.03) | 24.3611 |
| 2020's | 1 (2.70) | 2.80 |
| Authors | Studies |
|---|---|
| Hyeong, JH | 3 |
| Jung, JW | 3 |
| Seo, SB | 3 |
| Kim, HS | 3 |
| Kim, KH | 3 |
| Ali, B | 1 |
| ElMahdy, N | 1 |
| Elfar, NN | 1 |
| Gutiérrez, J | 1 |
| Vallejo, B | 1 |
| Barbosa, H | 1 |
| Pinzón, J | 1 |
| Delgado, G | 1 |
| DU, LQ | 1 |
| Yang, HL | 1 |
| Wu, XY | 1 |
| Wang, SG | 1 |
| Li, Y | 1 |
| Rkein, A | 1 |
| Ozog, D | 1 |
| Waibel, JS | 1 |
| Kosinski, AM | 1 |
| Pothen, JM | 1 |
| Panitch, A | 1 |
| Sivasankar, MP | 1 |
| Sapra, S | 1 |
| Stewart, JA | 1 |
| Mraud, K | 1 |
| Schupp, R | 1 |
| Fife, DJ | 1 |
| Dhall, S | 1 |
| Silva, JP | 1 |
| Liu, Y | 1 |
| Hrynyk, M | 1 |
| Garcia, M | 1 |
| Chan, A | 1 |
| Lyubovitsky, J | 1 |
| Neufeld, RJ | 1 |
| Martins-Green, M | 1 |
| Sadove, R | 1 |
| Sadick, NS | 1 |
| Palmisano, L | 1 |
| Bachmann, F | 1 |
| Erdmann, R | 1 |
| Hartmann, V | 1 |
| Wiest, L | 1 |
| Rzany, B | 1 |
| Guyot, A | 1 |
| Carbonnel, M | 1 |
| Frey, C | 1 |
| Pharisien, I | 1 |
| Uzan, M | 1 |
| Carbillon, L | 1 |
| Sachdeva, S | 1 |
| Lee, SY | 1 |
| Oh, JH | 1 |
| Kim, JC | 1 |
| Kim, YH | 1 |
| Kim, SH | 1 |
| Choi, JW | 1 |
| Ng, JD | 1 |
| Huynh, TH | 1 |
| Burgett, R | 1 |
| Huang, JJ | 1 |
| Song, YM | 2 |
| Liu, LM | 2 |
| Liu, L | 1 |
| Song, Y | 1 |
| Duan, H | 2 |
| Ding, Y | 1 |
| Lu, B | 2 |
| Zhang, ZW | 1 |
| Xu, XX | 1 |
| Yang, CD | 1 |
| Pang, XD | 1 |
| Ji, HR | 1 |
| Yan, JJ | 1 |
| Zhu, D | 1 |
| Xiao, G | 1 |
| Yu, DH | 1 |
| Wiggers, H | 1 |
| Nørrelund, H | 1 |
| Nielsen, SS | 1 |
| Andersen, NH | 1 |
| Nielsen-Kudsk, JE | 1 |
| Christiansen, JS | 1 |
| Nielsen, TT | 1 |
| Møller, N | 1 |
| Bøtker, HE | 1 |
| Choi, YS | 1 |
| Park, SN | 1 |
| Suh, H | 1 |
| Lowe, NJ | 1 |
| Ding, YL | 1 |
| Vleggaar, D | 1 |
| Beer, K | 1 |
| Lee, CK | 1 |
| Alexander, H | 1 |
| Kerl, H | 1 |
| Auböck, L | 1 |
| Bayer, U | 1 |
| In de Braekt, MM | 3 |
| Maltha, JC | 3 |
| Kuijpers-Jagtman, AM | 3 |
| Monheit, GD | 1 |
| Van Alphen, FA | 2 |
| Heino, A | 1 |
| Naukkarinen, A | 1 |
| Kulju, T | 1 |
| Törmälä, P | 1 |
| Pohjonen, T | 1 |
| Mäkelä, EA | 1 |
| Reed, JT | 1 |
| Joseph, AK | 1 |
| Bridenstine, JB | 1 |
| Aderriotis, D | 1 |
| Sàndor, GK | 1 |
| Demas, PN | 1 |
| Braun, TW | 1 |
| Al-Waiz, MM | 1 |
| Al-Sharqi, AI | 1 |
| Mikawa, Y | 1 |
| Hamagami, H | 1 |
| Shikata, J | 1 |
| Higashi, S | 1 |
| Yamamuro, T | 1 |
| Hyon, SH | 1 |
| Ikada, Y | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| 6 Month Double-Blind Randomized Placebo-Controlled Trial to Evaluate the Safety and Efficacy of Small Particle Hyaluronic Acid to Treat Acne Scars Located on the Cheeks and Forehead[NCT02955381] | 26 participants (Actual) | Interventional | 2017-03-28 | Terminated (stopped due to Liquidation of Research Department) | |||
| Split-face Study of Changing in Skin Physiology and Clinical Appearance After Microdroplet Placement of Stabilized Hyaluronic Acid in Aging Faces[NCT02312154] | Phase 4 | 25 participants (Actual) | Interventional | 2014-04-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
"We measured a elasticity by a reviscometer device (Courage & Khazaka, Cologne, Germany).~The range of elasticity was 0 (most elastic possible as) ~400 AU(Arbitrary Unit) (inelastic as possible)" (NCT02312154)
Timeframe: 12 weeks
| Intervention | AU (arbitrary unit) (Mean) |
|---|---|
| Treated Side (Restylane Vital) | 242.33 |
| Untreated Side | 271.15 |
"We measured an erythema index by a mexameter device (Courage & Khazaka, Cologne, Germany).~The range of erythema index is 0~999 AU(Arbitrary Unit). The range of erythema index was 0 (as non-erythematous as possible) ~999 AU (most erythematous possible)" (NCT02312154)
Timeframe: 12 weeks
| Intervention | AU (arbitrary unit) (Mean) |
|---|---|
| Treated Side (Restylane Vital) | 253.66 |
| Untreated Side | 243.53 |
The therapeutic outcome was assessed by investigator using the Global Aesthetic Improvement Scale (GAIS), which rates outcome on the following 5-point scale: 3, very much improved; 2, much improved; 1, improved; 0, no change; and -1, worse. (NCT02312154)
Timeframe: 12 weeks
| Intervention | scores on a scale (Mean) |
|---|---|
| Treated Side (Restylane Vital) | 1.38 |
| Untreated Side | 0 |
The therapeutic outcome was assessed by patient self-assessment using the Global Aesthetic Improvement Scale (GAIS), which rates outcome on the following 5-point scale: 3, very much improved; 2, much improved; 1, improved; 0, no change; and -1, worse (NCT02312154)
Timeframe: 12 weeks
| Intervention | scores on a scale (Mean) |
|---|---|
| Treated Side (Restylane Vital) | 1.33 |
| Untreated Side | 0 |
"We measured a hydration level by a corneometer device (Courage & Khazaka, Cologne, Germany).~The range of hydration level was 0 (as dry as possible) ~120 AU (Arbitrary Unit)(most moist possible)" (NCT02312154)
Timeframe: 12 weeks
| Intervention | AU (arbitrary unit) (Mean) |
|---|---|
| Treated Side (Restylane Vital) | 53.19 |
| Untreated Side | 46.75 |
"We measured a melanin index by a mexameter device (Courage & Khazaka, Cologne, Germany).~The range of melanin index was 0 (as bright as possible) ~999 AU (Arbitrary Unit) (most dark possible)." (NCT02312154)
Timeframe: 12 weeks
| Intervention | AU (arbitrary unit) (Mean) |
|---|---|
| Treated Side (Restylane Vital) | 147.25 |
| Untreated Side | 149.00 |
1 review available for lactic acid and Cicatrization
| Article | Year |
|---|---|
The Jessner's-trichloroacetic acid peel. An enhanced medium-depth chemical peel.
Topics: Acne Vulgaris; Chemexfoliation; Cicatrix; Drug Combinations; Ethanol; Face; Facial Dermatoses; Human | 1995 |
6 trials available for lactic acid and Cicatrization
| Article | Year |
|---|---|
Intradermal Injection of Poly-d, l-Lactic Acid Using Microneedle Fractional Radiofrequency for Acne Scars: An Open-Label Prospective Trial.
Topics: Acne Vulgaris; Cicatrix; Humans; Injections, Intradermal; Lactic Acid; Prospective Studies | 2022 |
Intradermal Injection of Poly-d, l-Lactic Acid Using Microneedle Fractional Radiofrequency for Acne Scars: An Open-Label Prospective Trial.
Topics: Acne Vulgaris; Cicatrix; Humans; Injections, Intradermal; Lactic Acid; Prospective Studies | 2022 |
Intradermal Injection of Poly-d, l-Lactic Acid Using Microneedle Fractional Radiofrequency for Acne Scars: An Open-Label Prospective Trial.
Topics: Acne Vulgaris; Cicatrix; Humans; Injections, Intradermal; Lactic Acid; Prospective Studies | 2022 |
Intradermal Injection of Poly-d, l-Lactic Acid Using Microneedle Fractional Radiofrequency for Acne Scars: An Open-Label Prospective Trial.
Topics: Acne Vulgaris; Cicatrix; Humans; Injections, Intradermal; Lactic Acid; Prospective Studies | 2022 |
Microneedling (Dermapen) and Jessner's solution peeling in treatment of atrophic acne scars: a comparative randomized clinical study.
Topics: Acne Vulgaris; Chemexfoliation; Cicatrix; Combined Modality Therapy; Cosmetic Techniques; Drug Combi | 2019 |
A Canadian study of the use of poly-L-lactic acid dermal implant for the treatment of hill and valley acne scarring.
Topics: Acne Vulgaris; Administration, Cutaneous; Adult; Biocompatible Materials; Canada; Cicatrix; Cosmetic | 2015 |
[Clinical study of prevention of epidural scar and adhesion with polylactic acid membrane].
Topics: Adult; Aged; Biocompatible Materials; Cicatrix; Diskectomy; Female; Humans; Intervertebral Disc Disp | 2004 |
Influence of insulin and free fatty acids on contractile function in patients with chronically stunned and hibernating myocardium.
Topics: Aged; Blood Glucose; Chronic Disease; Cicatrix; Cross-Over Studies; Diastole; Drug Combinations; Ech | 2005 |
Outcomes of irradiated polyglactin 910 Vicryl Rapide fast-absorbing suture in oral and scalp wounds.
Topics: Adult; Biocompatible Materials; Cicatrix; Humans; Lactic Acid; Mouth; Oral Surgical Procedures; Poly | 1999 |
30 other studies available for lactic acid and Cicatrization
| Article | Year |
|---|---|
In vitro analysis regarding the safety of components used in a film-based therapeutic system loaded with meglumine antimoniate and its activity toward Leishmania major experimental infections: a preliminary study.
Topics: Antiprotozoal Agents; Cell Line; Cell Survival; Chitosan; Cicatrix; Drug Carriers; Excipients; Fibro | 2013 |
Effect of poly(DL-lactide-co-glycolide) on scar formation after glaucoma filtration surgery.
Topics: Animals; Biocompatible Materials; Cicatrix; Filtering Surgery; Glaucoma; Lactic Acid; Polyglycolic A | 2013 |
Treatment of atrophic scars with fractionated CO2 laser facilitating delivery of topically applied poly-L-lactic acid.
Topics: Administration, Cutaneous; Adolescent; Adult; Aged; Atrophy; Cicatrix; Collagen; Dermatologic Agents | 2014 |
Dexamethasone Controlled Release on TGF-β1 Treated Vocal Fold Fibroblasts.
Topics: Biocompatible Materials; Cells, Cultured; Cicatrix; Collagen; Cytokines; Delayed-Action Preparations | 2015 |
Commentary on a Canadian study of the use of poly-L-lactic Acid dermal implant for the treatment of hill and valley acne scarring.
Topics: Biocompatible Materials; Cicatrix; Face; Female; Humans; Lactic Acid; Male; Patient Satisfaction; Po | 2015 |
Release of insulin from PLGA-alginate dressing stimulates regenerative healing of burn wounds in rats.
Topics: Administration, Cutaneous; Alginates; Animals; Bandages; Burns; Chemistry, Pharmaceutical; Cicatrix; | 2015 |
Injectable poly-L: -lactic acid: a novel sculpting agent for the treatment of dermal fat atrophy after severe acne.
Topics: Acne Vulgaris; Chronic Disease; Cicatrix; Esthetics; Female; Humans; Injections, Intradermal; Lactic | 2009 |
Case study involving use of injectable poly-L-lactic acid (PLLA) for acne scars.
Topics: Acne Vulgaris; Cellulose; Cicatrix; Female; Humans; Injections, Intradermal; Lactic Acid; Mannitol; | 2009 |
The spectrum of adverse reactions after treatment with injectable fillers in the glabellar region: results from the Injectable Filler Safety Study.
Topics: Adult; Aged; Aged, 80 and over; Biocompatible Materials; Cicatrix; Dermatologic Agents; Drug Combina | 2009 |
[Uterine rupture: risk factors, maternal and perinatal complications].
Topics: Adult; Apgar Score; Birth Injuries; Blood Transfusion; Cesarean Section; Cicatrix; Cohort Studies; F | 2010 |
Lactic acid peeling in superficial acne scarring in Indian skin.
Topics: Acne Vulgaris; Adult; Cicatrix; Female; Humans; India; Keratolytic Agents; Lactic Acid; Pilot Projec | 2010 |
In vivo conjunctival reconstruction using modified PLGA grafts for decreased scar formation and contraction.
Topics: Animals; Cell Adhesion; Cell Division; Cells, Cultured; Cicatrix; Conjunctiva; Epithelium, Corneal; | 2003 |
Complications of bioabsorbable orbital implants and fixation plates.
Topics: Absorbable Implants; Biocompatible Materials; Bone Plates; Cicatrix; Eyelid Diseases; Humans; Intern | 2004 |
[Experimental study on the polylactic acid glue in preventing epidural adhesion].
Topics: Adhesives; Animals; Biocompatible Materials; Cicatrix; Epidural Space; Female; Fibroblasts; Lactic A | 2005 |
[Experimental study on the prevention of epidural scar adhesion with polycaprolactone/polylactic acid membrane].
Topics: Animals; Biocompatible Materials; Cicatrix; Female; Lactic Acid; Laminectomy; Membranes, Artificial; | 2004 |
Adipose tissue engineering using mesenchymal stem cells attached to injectable PLGA spheres.
Topics: Adipocytes; Adipose Tissue; Alcian Blue; Animals; Anthraquinones; Azo Compounds; Blotting, Western; | 2005 |
Dispelling the myth: appropriate use of poly-L-lactic acid and clinical considerations.
Topics: Acne Vulgaris; Biodegradation, Environmental; Cicatrix; Humans; Lactic Acid; Polyesters; Polymers; P | 2006 |
Effect of polylactic acid glue in preventing epidural scar adhesion after laminectomy in rabbits.
Topics: Animals; Biocompatible Materials; Cicatrix; Lactic Acid; Laminectomy; Membranes, Artificial; Polyest | 2006 |
Soft-tissue augmentation and the role of poly-L-lactic acid.
Topics: Adult; Aged; Aged, 80 and over; Biocompatible Materials; Cicatrix; Cosmetic Techniques; Face; Female | 2006 |
A single-center, open-label study on the use of injectable poly-L-lactic acid for the treatment of moderate to severe scarring from acne or varicella.
Topics: Acne Vulgaris; Adult; Biocompatible Materials; Chickenpox; Cicatrix; Cosmetic Techniques; Face; Fema | 2007 |
Prevention of postlaminectomy scar formation.
Topics: Animals; Cicatrix; Dogs; Lactates; Lactic Acid; Laminectomy; Lumbar Vertebrae; Polyesters; Polymers; | 1984 |
[Formation and treatment of pathologic scars--clinical and micromorphologic investigations (author's transl)].
Topics: Adolescent; Adult; Betaine; Child; Cicatrix; Collagen; Drug Combinations; Female; Glycosaminoglycans | 1981 |
Poly-(L-lactic) acid membranes in palatal surgery in beagle dogs: clinical and histologic evaluation.
Topics: Animals; Biocompatible Materials; Biodegradation, Environmental; Cicatrix; Collagen; Connective Tiss | 1995 |
Maxillary arch dimensions after palatal surgery and implantation of poly-(L-lactic) acid membranes in beagle dogs.
Topics: Analysis of Variance; Animals; Cicatrix; Dental Arch; Dogs; Lactates; Lactic Acid; Maxilla; Membrane | 1993 |
Characteristics of poly(L-)lactic acid suture applied to fascial closure in rats.
Topics: Abdominal Muscles; Animals; Cicatrix; Lactic Acid; Male; Microscopy, Electron, Scanning; Polyesters; | 1996 |
Treatment of periorbital wrinkles. A comparison of the SilkTouch carbon dioxide laser with a medium-depth chemical peel.
Topics: Administration, Cutaneous; Adult; Aged; Carbon Dioxide; Chemexfoliation; Cicatrix; Drug Combinations | 1997 |
Chemical skin resurfacing.
Topics: Anesthesia, Local; Chemexfoliation; Cicatrix; Dermatologic Agents; Dermatologic Surgical Procedures; | 1998 |
Medium-depth chemical peels in the treatment of acne scars in dark-skinned individuals.
Topics: Acne Vulgaris; Adolescent; Adult; Caustics; Chemexfoliation; Cicatrix; Drug Combinations; Drug Thera | 2002 |
Wound healing and wound contraction after palatal surgery and implantation of poly-(L-lactic) acid membranes in beagle dogs.
Topics: Analysis of Variance; Animals; Cicatrix; Dogs; Lactates; Lactic Acid; Membranes, Artificial; Palate; | 1992 |
An experimental study on prevention of postlaminectomy scar formation by the use of new materials.
Topics: Animals; Biocompatible Materials; Cicatrix; Lactates; Lactic Acid; Laminectomy; Membranes, Artificia | 1986 |